Codexis (CDXS) Appoints Arthur Levin to Strategic Advisory Board

Go back to Codexis (CDXS) Appoints Arthur Levin to Strategic Advisory Board

Codexis Appoints Arthur Levin, PhD, to Strategic Advisory Board

February 6, 2025 4:05 PM UTC


REDWOOD CITY, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Companys Strategic Advisory Board (SAB). Dr. Levin is a founding member of Avidity Biosciences, a biopharmaceutical company committed to delivering a new class of RNA therapeutics called antibody oligonucleotide... More